APA

Bočkor L., Bortolussi G., Iaconcig A., Chiaruttini G., Tiribelli C., Giacca M., Benvenuti F., Zentilin L. & Muro A. F. (20180326). Repeated AAV-mediated gene transfer by serotype switching enables long-lasting therapeutic levels of hUgt1a1 enzyme in a mouse model of Crigler-Najjar Syndrome Type I. : Gene therapy.

Chicago

Bočkor L, Bortolussi G, Iaconcig A, Chiaruttini G, Tiribelli C, Giacca M, Benvenuti F, Zentilin L and Muro A F. 20180326. Repeated AAV-mediated gene transfer by serotype switching enables long-lasting therapeutic levels of hUgt1a1 enzyme in a mouse model of Crigler-Najjar Syndrome Type I. : Gene therapy.

Harvard

Bočkor L., Bortolussi G., Iaconcig A., Chiaruttini G., Tiribelli C., Giacca M., Benvenuti F., Zentilin L. and Muro A. F. (20180326). Repeated AAV-mediated gene transfer by serotype switching enables long-lasting therapeutic levels of hUgt1a1 enzyme in a mouse model of Crigler-Najjar Syndrome Type I. : Gene therapy.

MLA

Bočkor L, Bortolussi G, Iaconcig A, Chiaruttini G, Tiribelli C, Giacca M, Benvenuti F, Zentilin L and Muro A F. Repeated AAV-mediated gene transfer by serotype switching enables long-lasting therapeutic levels of hUgt1a1 enzyme in a mouse model of Crigler-Najjar Syndrome Type I. : Gene therapy. 20180326.